Advertisement
Research Article

Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors

  • Fares Al-Ejeh,

    Affiliation: Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia

    X
  • Jocelyn M. Darby,

    Affiliation: Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia

    X
  • Michael P. Brown mail

    michael.brown@health.sa.gov.au

    Affiliations: Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia, Department of Medical Oncology, Royal Adelaide Hospital and School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Published: February 27, 2009
  • DOI: 10.1371/journal.pone.0004630

About the Authors

Fares Al-Ejeh, Jocelyn M. Darby, Michael P. Brown
Experimental Therapeutics Laboratory, Hanson Institute, Adelaide, South Australia, Australia
Michael P. Brown
Department of Medical Oncology, Royal Adelaide Hospital and School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia

Corresponding Author

Email: michael.brown@health.sa.gov.au

Competing Interests

FA, JMD, and MPB are named as inventors on patent applications, which are licensed to Oncaidia. FA and MPB are members of the scientific advisory board of Oncaidia.

Author Contributions

Conceived and designed the experiments: FAE MPB. Performed the experiments: FAE JMD. Analyzed the data: FAE JMD MPB. Contributed reagents/materials/analysis tools: FAE. Wrote the paper: FAE MPB.